Search results summary
From Health Canada
Search criteria
- Status: Select all
- AIG: 0111558002
Search results
Status | DIN | Company | Product | Class | PM See footnote1 | Schedule | # See footnote2 | A.I. name See footnote3 | Strength |
---|---|---|---|---|---|---|---|---|---|
Cancelled Pre Market | 02365278 | ACCEL PHARMA INC | ACCEL-CLONAZEPAM | Human | Yes | Targeted (CDSA IV) | 1 | CLONAZEPAM | 2.0 MG |
Marketed | 02177897 | APOTEX INC | APO-CLONAZEPAM | Human | Yes | Targeted (CDSA IV) | 1 | CLONAZEPAM | 2 MG |
Dormant | 02230369 | BAUSCH HEALTH, CANADA INC. | CLONAPAM | Human | Yes | Targeted (CDSA IV) | 1 | CLONAZEPAM | 2 MG |
Approved | 02173352 | APOTEX INC | CLONAZEPAM | Human | Yes | Targeted (CDSA IV) | 1 | CLONAZEPAM | 2 MG |
Cancelled Post Market | 02344610 | MELIAPHARM INC | CLONAZEPAM | Human | Yes | Targeted (CDSA IV) | 1 | CLONAZEPAM | 2 MG |
Cancelled Post Market | 02442051 | SIVEM PHARMACEUTICALS ULC | CLONAZEPAM | Human | Yes | Targeted (CDSA IV) | 1 | CLONAZEPAM | 2 MG |
Cancelled Post Market | 02220601 | PRO DOC LIMITEE | CLONAZEPAM-2 - TAB 2MG | Human | No | Targeted (CDSA IV) | 1 | CLONAZEPAM | 2 MG |
Cancelled Post Market | 02270676 | COBALT PHARMACEUTICALS COMPANY | CO CLONAZEPAM | Human | Yes | Targeted (CDSA IV) | 1 | CLONAZEPAM | 2.0 MG |
Cancelled Post Market | 02131013 | DOMINION PHARMACAL | DOM-CLONAZEPAM - TAB 2MG | Human | Yes | Targeted (CDSA IV) | 1 | CLONAZEPAM | 2 MG |
Cancelled Post Market | 02230951 | MYLAN PHARMACEUTICALS ULC | MYLAN-CLONAZEPAM | Human | Yes | Targeted (CDSA IV) | 1 | CLONAZEPAM | 2 MG |
Cancelled Post Market | 02145243 | PHARMEL INC | PHL-CLONAZEPAM - TAB 2MG | Human | Yes | Targeted (CDSA IV) | 1 | CLONAZEPAM | 2 MG |
Marketed | 02048736 | PHARMASCIENCE INC | PMS-CLONAZEPAM | Human | Yes | Targeted (CDSA IV) | 1 | CLONAZEPAM | 2 MG |
Marketed | 02311615 | PRO DOC LIMITEE | PRO-CLONAZEPAM | Human | Yes | Targeted (CDSA IV) | 1 | CLONAZEPAM | 2 MG |
Cancelled Post Market | 02103737 | RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED | RATIO-CLONAZEPAM | Human | No | Targeted (CDSA IV) | 1 | CLONAZEPAM | 2 MG |
Marketed | 02242078 | LABORATOIRE RIVA INC. | RIVA-CLONAZEPAM | Human | Yes | Targeted (CDSA IV) | 1 | CLONAZEPAM | 2 MG |
Marketed | 00382841 | CHEPLAPHARM ARZNEIMITTEL GMBH | RIVOTRIL | Human | Yes | Targeted (CDSA IV) | 1 | CLONAZEPAM | 2 MG |
Cancelled Post Market | 02233985 | SANDOZ CANADA INCORPORATED | SANDOZ CLONAZEPAM | Human | Yes | Targeted (CDSA IV) | 1 | CLONAZEPAM | 2 MG |
Cancelled Post Market | 02239025 | TEVA CANADA LIMITED | TEVA-CLONAZEPAM | Human | Yes | Targeted (CDSA IV) | 1 | CLONAZEPAM | 2 MG |
Cancelled Post Market | 02303337 | ZYMCAN PHARMACEUTICALS INC | ZYM-CLONAZEPAM | Human | Yes | Targeted (CDSA IV) | 1 | CLONAZEPAM | 2 MG |
Application information
Related information
Contact us
Version 4.0.3